


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.79%
+4.12%
-6.02%
-0.74%
BSX
Boston Scientific
$98.65
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Trading below its fair value
Risk Analysis

Investors losing their confidence
BSX Price Performance
$92.7 (+6.42%)
$94.95 (+3.90%)
$103.17 (-4.38%)
$103.17 (-4.38%)
BSX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

BSX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Outperform the market

Trading below its fair value
![]()
BSX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BSX Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels
SYK
367.75
+0.37%
BDX
202.71
-1.26%
TFX
126.53
+1.66%
RMD
248.21
-0.39%
PROF
8.19
+5.89%
What is BSX current stock price?
What are BSX stock strengths?
What is BSX Risk Level?
What is BSX market cap and volume?
What is BSX current Stock IQ?
Should I buy BSX stock right now?
Is BSX a Strong Buy right now?
What does a 'Strong Buy' rating mean for BSX?
What does a 'Strong Sell' rating mean for BSX?
What factors influence BSX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.79%
+4.12%
-6.02%
-0.74%
BSX
Boston Scientific
Current Price
$98.65
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Trading below its fair value
Risk Analysis

Investors losing their confidence
Linked to BSX
SYK
367.75
+0.37%
BDX
202.71
-1.26%
TFX
126.53
+1.66%
RMD
248.21
-0.39%
PROF
8.19
+5.89%

BSX Price Performance
$92.7 (+6.42%)
$94.95 (+3.90%)
$103.17 (-4.38%)
$103.17 (-4.38%)
BSX Analysts Opinion
BSX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Outperform the market

Trading below its fair value
![]()
BSX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BSX Street Sentiment is bullish and have positive views on the near-term outlook
BSX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
BSX Stock IQ
BSX Latest Analysis
How Is Boston Scientifics Cardiovascular Growth Path Shaping Up?. BSXs $50B cardiovascular business aims to outpace market growth across EP WATCHMAN ICTx and more.
Wed Dec 31, 2025
Peter Lynch Detailed Fundamental Analysis - BSX. Below is Valideas guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow BSX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price re
Mon Dec 29, 2025
Peter Lynch Detailed Fundamental Analysis - BSX. Below is Valideas guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow BSX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price re
Fri Dec 26, 2025
A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook.
Fri Dec 26, 2025
BSX Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow BSX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price re
Wed Dec 24, 2025
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth?. BSXs Endoscopy unit targets an $8B market spanning pancreaticobiliary surgery and obesity with plans to outgrow the market.
Wed Dec 24, 2025
Should You Hold On To BSX Stock Despite Its Premium Valuation?. Boston Scientific trades at a premium but strong momentum in WATCHMAN EP and MedSurg growth keeps long-term shareholders in the game despite valuation risks.
Tue Dec 23, 2025
Is Boston Scientific Corp. (BSX) Positioned for Solid Durable Growth?. Parnassus Investments an investment management company released the Parnassus Core Equity Fund third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&.P 500 Index surged in the third quarter driven by investor optimism that grew on expectations of monetary easing strong consumer demand and solid corporate earnings. The Fund (Investor [….]
Tue Dec 23, 2025
Is Boston Scientific (BSX) One of the Best Healthcare AI Stocks to Buy Now?. Boston Scientific Corporation (NYSE:BSX) is one of the best healthcare AI stocks to buy now. On December 12 TD Cowen reaffirmed a Buy rating on Boston Scientific Corporation (NYSE:BSX) and kept a $115 price target. The firm went a step further to name Boston Scientific their Best Idea for 2026. TD Cowen called Boston Scientific [….]
Mon Dec 22, 2025
Peter Lynch Detailed Fundamental Analysis - BSX. Below is Valideas guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow BSX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price re
Mon Dec 22, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.